Costs due to disease for the leading 20 diagnostic categories, by direct and indirect costs, Canada, 2000

Figure 1-4: Costs due to disease* for the leading 20 diagnostic categories, by direct**, and indirect costs***, Canada, 2000

 

Costs due to disease for the leading 20 diagnostic categories, by direct and indirect costs, in Canada in 2000 are shown in Figure 1-4.

In 2000, musculoskeletal diseases had the highest total costs of all diagnostic categories, at $22.2 billion. Indirect costs accounted for more than $18 billion of the total costs.

 Based on the total cost of illness of $147.9 billion. Expenditures for care in other institutions and additional direct health expenditures are not included.

**Direct costs include hospitals, drugs and physician.
*** Indirect costs include mortality, long-term disability and short-term disability.

Notes:

• Not all diagnostic categories include short-term disability costs. 
• The six diagnostic categories that include short-term disability costs are CVD, musculoskeletal diseases, neuropsychiatric conditions, digestive diseases, respiratory diseases and respiratory infections. 
• Costs by diagnostic category include an unattributable amount of $6.4 billion for direct costs and $1.9 billion for indirect costs (short-term disability only). 
• Costs by disgnostic category related to suppressed cells for long-term disability are excluded from the total indirect costs.

Source: Public Health Agency of Canada, using data from the Economic Burden of Illness in Canada 2000.